Francesca Puggioni, MD, explains how real-world registry data, like the EU-ADVANTAGE study, informs regulatory decisions on ...

VHA/CMS screening identified 11,809 veterans with PV; after exclusions, 5,287 and 5,245 were analyzed for mortality and ...

Ifosfamide shortages affect 94% of centers, with notable constraints also reported for carboplatin, cisplatin, BCG, and ...

Policy changes could have the greatest impact on transplant equity, explains hematologic oncologist Karilyn Larkin, MD. Clinical trials and transplantation remain critical components of care for ...

In "Inside the Be Well Trials: Design, Population, and Patient Selection," the panel walks through why the Be Well trials ...

In "Cross-Trial Vitiligo Data: What Payers Can and Can't Compare," the panel compares cross-trial data directly and discusses ...

This episode, "How Bepirovirsen Targets the Hepatitis B Viral Lifecycle," features the panel debating how much of this ...

Jorgen Vestbo, MD, on the COPERNICOS trial results, long-term antibiotic use versus resistance concerns, and where COPD treatment is headed. The COPERNICOS (NCT04481555) trial, a multicenter, ...

New Harris Poll data show mental health, access, and postpartum care gaps persist for US mothers, with Black and Hispanic women hit hardest.

The share of children aged 8 to 11 years with obesity who were prescribed glucagon-like peptide-1 (GLP-1) receptor agonists rose 310-fold between January 2019 and June 2026, even though absolute use ...

Francesca Puggioni, MD, discusses real-world exacerbations, biomarker-driven access, and barriers to earlier biologic use in asthma and COPD. Panel discussions and abstract presentations at the ...

Economic modeling suggested meaningful savings via reduced disability costs and avoidance of inpatient admissions for compounded ophthalmic therapy, with projected annual patient savings of roughly ...